The coughing and coughing is usually a fever symptoms
Mohammad Hosein Safaei / Not Write
People with hay fever can be a day to benefit from a first-in-very “molecule molecule with the nasal content.
Hay fever is an allergic reaction when pollen binding molecules called antibodies in the nasal line, mouth, inflammation of inflammation. Treatments include antihistamines and steroids, which demubs inflammation, but not always effective and often with side effects, such as dizziness.
To find an option, Kissar Tabynov In Kazakh National Agrarian Search University in Kazakhstan and his companions collected blood samples from rats. They immediately took an antibody not involved in allergic reactions, but still tied to the main allergy to Mugwort pollen, a factor that caused Hay Fever. This binding then blocks allergen from attaching ige antibodies in a lab dish. “It acts like a molecule molecule,” Tabynov said.
To find out if it can reduce irritation, researchers prompts pollen in Mugwort allergies Of 10 mice by injecting them with alermen and a chemical training their resistance react.
A week later, they put a small drop of liquid with pollen-blocking antibody of the noses of half mice, which makes total three times. The remaining animals are given dropletal solutions to saline. One hour after each droplet was administered, the mice were exposed to mugwort pollen on levels similar to people who were exposed during peak hays fever season, as Tabynov.
After the final droplet, the rats given the control of antibody rubbed their noses 12 times, on average, over 5 minutes, 92 times in the saline group.
Researchers expect antibody to reduce inflammation, which they certify when decorated tissue samples collected from the rats at the end of the end of the study. It also shows that treatment has effects deep inside the body, not only where droplets are used. “Our study was the first to show that a monoclonal monoclonal antibodal could be used intranasally to achieve the context of pollen plants,” says Tabynov.
Although researchers do not measure potential impacts, they do not expect the method to see evil events with fever medicines, because they work on the Elergen Strots site.
“This study is an important important, promoting the potential of intranasal therapies for allergic rhinitis (hay fever to investigate the potential of this method of people,” as Sayrantanti sindher In Stanford University in California.
But success in rats may not undress the effectiveness of humans and antibody should be adapted to make people make sure it doesn’t make self-resistant resistance, as Tabynov. If everyone is smooth, the team hopes to settle the way as a dispute with people’s nose in the next two to three years, he said.
Such sprays can also work against other types of pollen causing hay fever. “We looked at a future where charged with antibody sprays can be used for people allergic to different types of pollens,” Tabynov said.
Topics:
